# Surgical Treatment of Ischemic Mitral Regurgitation

Study · id `cardio:ct-nct01368575` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01368575](<https://clinicaltrials.gov/study/NCT01368575>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01368575

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 420 participants.

## Technical summary

Registry record NCT01368575. Randomized; single masking; primary purpose treatment. Start 2011-05 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 420 participants (planned count; ClinicalTrials.gov record NCT01368575, source copy `cardio:ctgov-nct01368575-2015-09-23`, retrieved 2026-10-26)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01368575, source copy `cardio:ctgov-nct01368575-2015-09-23`, retrieved 2026-10-26)
- Primary completion: 2014-05 (actual) (ClinicalTrials.gov record NCT01368575, source copy `cardio:ctgov-nct01368575-2015-09-23`, retrieved 2026-10-26)
- Completion: 2015-11 (anticipated) (ClinicalTrials.gov record NCT01368575, source copy `cardio:ctgov-nct01368575-2015-09-23`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT01368575, source copy `cardio:ctgov-nct01368575-2015-09-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01368575-2015-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Surgical Treatment of Ischemic Mitral Regurgitation
- Acronym: TIME
- Condition: Mitral Valve Insufficiency
- Intervention (Procedure): CABG
- Intervention (Procedure): CABG combined with MV repair with remodeling annuloplasty rigid ring
- Intervention (Procedure): CABG combined with MV repair with remodeling annuloplasty rigid ring
- Intervention (Procedure): CABG combined with MV repair with remodeling annuloplasty rigid ring and endoventricularplasty of subvalvular apparatus
- Intervention (Procedure): CABG and MV replacement
- Lead sponsor: Meshalkin Research Institute of Pathology of Circulation
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Meshalkin Research Institute of Pathology of Circulation (`cardio:org-meshalkin-research-institute-of-pathology-of-circulation`)

## Provenance

Content hash: 744a0f6aadc5bd11147b67b7b0ee660a5626c32dd172ef66ad2d08c291228be4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
